Blue-Light Endoscope Trial Closed

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 5
Volume 4
Issue 5

RICHMOND, BC, Canada--Xillix Technologies Corp. has closed the North American multicenter clinical trial of its LIFE (lung imaging fluorescence endoscope)-Lung Imaging System that began in April, 1993.

RICHMOND, BC, Canada--Xillix Technologies Corp. has closed theNorth American multicenter clinical trial of its LIFE (lung imagingfluorescence endoscope)-Lung Imaging System that began in April,1993.

The system uses tissue autofluo-rescence to enhance the physician'sability to locate suspicious lung tissue for biopsy. By usingblue rather than conventional white light, the system can pickup subtle differences between precancerous or cancerous tissueand normal tissue, the company said.

Preliminary data showed a relative improvement of 161% in theability to identify suspicious tissue for moderate to severe dysplasiaor worse when the LIFE System was used as an adjunct to whitelight bronchoscopy versus white light bronchoscopy alone.

Recent Videos
Educating community practices on CAR T referral and sequencing treatment strategies may help increase CAR T utilization.
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
9 Experts are featured in this series.
9 Experts are featured in this series.
Harmonizing protocols across the health care system may bolster the feasibility of giving bispecifics to those with lymphoma in a community setting.
2 experts are featured in this series.
Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
9 Experts are featured in this series.
Related Content